Literature DB >> 16823770

Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system.

Sylvie Lamy1, René Lafleur, Valérie Bédard, Albert Moghrabi, Stéphane Barrette, Denis Gingras, Richard Béliveau.   

Abstract

Complete resection of malignant glioblastomas is usually impossible because of diffuse and widespread invasion of tumor cells, and complementary approaches need to be developed in order to improve the efficacy of current treatments. Consumption of fruits and berries has been associated with decreased risk of developing cancer and there is great interest in the use of molecules from dietary origin to improve anticancer therapies. In this work, we report that the aglycons of the most abundant anthocyanins in fruits, cyanidin (Cy), delphinidin (Dp), and petunidin (Pt), act as potent inhibitors of glioblastoma cell migration. Dp clearly exhibited the highest inhibitory potency, this effect being related to the ortho-dihydroxyphenyl structure on the B-ring and the presence of a free hydroxyl group at position 3. Dp decreases the expression of both urokinase-type plasminogen activator receptor (uPAR) and the low-density lipoprotein receptor-related protein (LRP), acting at the transcriptional levels. In addition, Dp upregulated urokinase-type plasminogen activator (uPA) and downregulated the plasminogen activator inhibitor-1 (PAI-1) but decreased, in a concentration-dependent manner, the uPA-dependent conversion of plasminogen to plasmin, indicating that the upregulation of uPA observed with these compounds was not associated with induction of the plasminolytic activity. Overall, these results demonstrate that Dp, Pt, and Cy affect plasminogen activation, thus leading to the inhibition of glioblastoma cell migration and therefore they may be helpful for the development of new strategies for cancer prevention and therapy. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16823770     DOI: 10.1002/jcb.21023

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

Review 1.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

Review 2.  Effects of anthocyanins on the prevention and treatment of cancer.

Authors:  Bo-Wen Lin; Cheng-Chen Gong; Hai-Fei Song; Ying-Yu Cui
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

Review 3.  Drug resistance in glioblastoma: a mini review.

Authors:  Catherine P Haar; Preetha Hebbar; Gerald C Wallace; Arabinda Das; William A Vandergrift; Joshua A Smith; Pierre Giglio; Sunil J Patel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2012-01-10       Impact factor: 3.996

4.  Selective in vitro anticancer effect of blueberry extract (Vaccinium virgatum) against C6 rat glioma: exploring their redox status.

Authors:  Larissa Menezes da Silveira; Nathalia Stark Pedra; Natália Pontes Bona; Luiza Spohr; Francieli da Silva Dos Santos; Juliane Torchelsen Saraiva; Fernando Lopez Alvez; Bernardo de Moraes Meine; Roselia Maria Spanevello; Francieli Moro Stefanello; Mayara Sandrielly Pereira Soares
Journal:  Metab Brain Dis       Date:  2021-11-08       Impact factor: 3.584

5.  Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase.

Authors:  Jung Yeon Kwon; Ki Won Lee; Jong-Eun Kim; Sung Keun Jung; Nam Joo Kang; Mun Kyung Hwang; Yong-Seok Heo; Ann M Bode; Zigang Dong; Hyong Joo Lee
Journal:  Carcinogenesis       Date:  2009-09-23       Impact factor: 4.944

6.  Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation.

Authors:  Deeba N Syed; Farrukh Afaq; Sami Sarfaraz; Naghma Khan; Rajendra Kedlaya; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-09       Impact factor: 4.219

7.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

8.  Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: a randomized controlled trial.

Authors:  Xiandan Zhang; Yanna Zhu; Fenglin Song; Yanling Yao; Fuli Ya; Dan Li; Wenhua Ling; Yan Yang
Journal:  Nutr Metab (Lond)       Date:  2016-11-25       Impact factor: 4.169

9.  Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.

Authors:  Ruey-Hwang Chou; Shu-Ching Hsieh; Yung-Luen Yu; Min-Hsien Huang; Yi-Chang Huang; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.

Authors:  Jen-Pi Tsai; Pei-Ching Hsiao; Shun-Fa Yang; Shu-Ching Hsieh; Da-Tian Bau; Chu-Liang Ling; Chun-Li Pai; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.